JP2009544676A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544676A5
JP2009544676A5 JP2009521335A JP2009521335A JP2009544676A5 JP 2009544676 A5 JP2009544676 A5 JP 2009544676A5 JP 2009521335 A JP2009521335 A JP 2009521335A JP 2009521335 A JP2009521335 A JP 2009521335A JP 2009544676 A5 JP2009544676 A5 JP 2009544676A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
compound
halogen
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009521335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544676A (ja
JP5468900B2 (ja
Filing date
Publication date
Priority claimed from GB0614678A external-priority patent/GB0614678D0/en
Priority claimed from GB0614677A external-priority patent/GB0614677D0/en
Priority claimed from GB0704648A external-priority patent/GB0704648D0/en
Priority claimed from GB0704645A external-priority patent/GB0704645D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/002815 external-priority patent/WO2008012524A1/en
Publication of JP2009544676A publication Critical patent/JP2009544676A/ja
Publication of JP2009544676A5 publication Critical patent/JP2009544676A5/ja
Application granted granted Critical
Publication of JP5468900B2 publication Critical patent/JP5468900B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009521335A 2006-07-24 2007-07-24 置換されたアニリン誘導体 Expired - Fee Related JP5468900B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0614678A GB0614678D0 (en) 2006-07-24 2006-07-24 Substituted aniline derivatives
GB0614677A GB0614677D0 (en) 2006-07-24 2006-07-24 Substituted Aniline Derivatives
GB0614678.1 2006-07-24
GB0614677.3 2006-07-24
GB0704645.1 2007-03-09
GB0704648A GB0704648D0 (en) 2007-03-09 2007-03-09 Substituted aniline derivatives
GB0704645A GB0704645D0 (en) 2007-03-09 2007-03-09 Substituted aniline derivatives
GB0704648.5 2007-03-09
PCT/GB2007/002815 WO2008012524A1 (en) 2006-07-24 2007-07-24 Substituted aniline derivatives

Publications (3)

Publication Number Publication Date
JP2009544676A JP2009544676A (ja) 2009-12-17
JP2009544676A5 true JP2009544676A5 (enExample) 2013-07-04
JP5468900B2 JP5468900B2 (ja) 2014-04-09

Family

ID=38484243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521335A Expired - Fee Related JP5468900B2 (ja) 2006-07-24 2007-07-24 置換されたアニリン誘導体

Country Status (6)

Country Link
US (3) US7678785B2 (enExample)
EP (1) EP2046739B1 (enExample)
JP (1) JP5468900B2 (enExample)
AU (1) AU2007279092B2 (enExample)
CA (1) CA2658913C (enExample)
WO (1) WO2008012524A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007279092B2 (en) * 2006-07-24 2012-12-13 Ucb Pharma S.A. Substituted aniline derivatives
MX2009004619A (es) * 2006-10-31 2009-05-15 Cadila Healthcare Ltd Agonistas selectivos del receptor tiroideo (tr) beta 1.
TWI386204B (zh) * 2008-04-10 2013-02-21 Mitsubishi Tanabe Pharma Corp 高半胱胺酸合成酶抑制劑
EP2297102A1 (en) * 2008-06-16 2011-03-23 F. Hoffmann-La Roche AG Heteroaromatic monoamides as orexinin receptor antagonists
WO2011043480A1 (ja) * 2009-10-09 2011-04-14 田辺三菱製薬株式会社 ホモシステイン合成酵素阻害薬
US20130316029A1 (en) * 2010-12-21 2013-11-28 Nestec S.A. Methods and compositions suitable for managing blood glucose in animals
RU2541532C2 (ru) * 2012-10-16 2015-02-20 Федеральное Государственное Бюджетное Учреждение Науки Институт Нефтехимии И Катализа Ран Ди-[4-(диметиламинометилсульфанил)-фениловый] эфир щавелевокислый - водорастворимое средство для борьбы с почвенной и поверхностно-семенной инфекцией
CN106563929B (zh) 2015-10-08 2019-09-17 利宝地工程有限公司 修复和制造涡轮发动机部件的方法及涡轮发动机部件
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
CN108172553A (zh) * 2018-01-17 2018-06-15 杭州暖芯迦电子科技有限公司 一种视网膜假体植入芯片的封装结构及其封装方法
CN116947678B (zh) * 2023-07-24 2025-07-08 河南大学 一类氮原子双取代芳香环类小分子有机化合物及其衍生物及其在制备抗菌药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676188A (en) * 1950-12-16 1954-04-20 American Home Prod Acylated glycinamides
US4205168A (en) * 1973-09-24 1980-05-27 Chevron Research Company N-Carbamylalkyl-2,6-dialkyl-α-haloacetanilides
JPS51125741A (en) * 1974-10-17 1976-11-02 Chevron Res Weed killer
US3944607A (en) * 1974-10-17 1976-03-16 Chevron Research Company Herbicidal N-(N'-alkynylcarbamylmethyl)-2,6-dialkyl-α-haloacetanilides
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"
JPS58154567A (ja) * 1982-03-09 1983-09-14 Teikoku Chem Ind Corp Ltd チオフエノ−ル誘導体及びその製造方法
US4736066A (en) * 1982-07-19 1988-04-05 E. R. Squibb & Sons, Inc. Intermediate for substituted peptide compounds
JPH01211560A (ja) * 1988-02-18 1989-08-24 Sagami Chem Res Center β−ラクタム誘導体の製造方法
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
JP4751567B2 (ja) * 2000-09-14 2011-08-17 田辺三菱製薬株式会社 新規アミド誘導体およびその医薬としての用途
RU2247716C2 (ru) 2003-03-27 2005-03-10 Российский химико-технологический университет им. Д.И. Менделеева (РХТУ) Замещенные метил-n-амидооксамоил-n-фенил-d, l-аланинаты и их способы получения
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
JP2005202314A (ja) * 2004-01-19 2005-07-28 Fuji Photo Film Co Ltd 重合性組成物及びそれを用いた画像形成材料
WO2005077948A1 (ja) * 2004-02-16 2005-08-25 Daiichi Pharmaceutical Co., Ltd. 抗真菌作用複素環化合物
WO2006012441A1 (en) * 2004-07-23 2006-02-02 Susan Marie Royalty Peptidase inhibitors
WO2006106711A1 (ja) * 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
US7737166B2 (en) * 2005-08-17 2010-06-15 Daiichi Sankyo Company, Limited Antifungal bicyclic hetero ring compounds
AU2007279092B2 (en) 2006-07-24 2012-12-13 Ucb Pharma S.A. Substituted aniline derivatives

Similar Documents

Publication Publication Date Title
ES2213775T3 (es) Metodos de lucha contra las enfermedades infecciosas utilizando bis-benzimidazol dicationicos.
EP2146721B1 (en) Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
ES2682328T3 (es) Derivados de la anfotericina B con índice terapéutico mejorado
JP2011500779A5 (enExample)
ZA200502384B (en) Non-nucleoside reverse transcriptase inhibitors
WO1997006804A1 (en) 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
KR20090013827A (ko) Ｈｉｖ 환자에서 면역 재구성을 증진시키고 기회 감염을 치료하기 위한 ｃｃｒ５ 길항제
CN101175491B (zh) 磺酰胺化合物用于提高药物的药代动力学的用途
JP2023109899A (ja) 少なくとも１つのスプライソソームモジュレーターと、ｂｃｌ２阻害剤、ｂｃｌ２／ｂｃｌｘｌ阻害剤及びｂｃｌｘｌ阻害剤から選択される少なくとも１つの阻害剤とを含む組合せ、並びに使用の方法
US8147852B2 (en) Modified azole compounds as antifungal and antibacterial agents
JPH11504931A (ja) 抗真菌組成物
JP2002505662A (ja) ヒドロキシム酸誘導体及び抗ウイルス薬を含有する抗ウイルス活性を有する薬剤組成物
CN101522195B (zh) 含有苯基脒衍生物的药物组合物和该药物组合物与抗真菌剂的联合使用方法
CN101610776A (zh) 包含CNDAC(2′-氰基-2′-脱氧-N4 -棕榈酰基-1-β-D-阿拉伯呋喃糖基-胞嘧啶)和细胞毒剂的组合
EP2094358A2 (en) Imidazoles for treating multi-drug resistant bacterial infections
JP2010534199A5 (enExample)
WO2014048377A1 (zh) 治疗肿瘤的组合药物及其应用
EP1713477B1 (en) Combination of voriconazole and an antifungal cyp2c19 inhibitor
CN103230363A (zh) 一种抗真菌的口服溶液
CN115811989A (zh) 抗真菌前体药物
WO2014202497A1 (en) Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy
JPH07508998A (ja) 抗ウイルス剤の組み合わせ
JP2022543421A5 (enExample)
EP3010513B1 (en) Combination of ro5503781 and capecitabine for cancer therapy
ES2990069A1 (es) Combinacion sinergica para el tratamiento de cancer